Q-omics provides the consensus-scored MIR205 profile across patient tissues and cancer cell-line models. Additionally, MIR205 RNA expression shows 7,212 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR205 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with MIR205 in patient tissues and cancer cell lines. In patient samples, MIR205 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, MIR205 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	7,212	LSCC (3746)	view →
Function (mass-spec)	581	LSCC (235)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,710	BLOOD_Leukemia (536)	view →
shRNA	1,190	BLOOD_Leukemia (144)	view →